Hello, everyone:

We are ready for the next GRADE webinar organized by the GRADE working group and the Cochrane Applicability and Recommendations Methods Group (ARMG) to answer questions about the GRADE approach. We have received a lot of questions and we cannot thank you enough for your support.

Date and time

Friday, April 26th, 2013
09:00 hours EST/EDT (Toronto) (GMT -05:00)
Check your time zone here

Host

Elie Akl will be our host this month

The link to enter

The Elluminate room link, provided by PAHO (you can enter on the specific date 15 minutes before the webinar begins)
A new window shall open and ask you to register a user name. After that, it will ask you to download a Java based software, easy to install and use, and you are set up!

See you on friday.

If you have a question you can stil send it to:

[log in to unmask]

It is IMPORTANT that the subject of your mail be:

question for GRADE and Cochrane ARMG webinar

If your question is not discussed this time, don’t worry, we will discuss it on the next webinar.

The webinars began on February 2013 and have been recorded on Elluminate (support kindly provided by PAHO via Luis Gabriel Cuervo) and you can watch them here.

Please, circulate this information to whomever you consider might be interested

Many thanks to all!

--
Carlos A. Cuello-García, MD
Centre for Evidence Based Practice & Knowledge Translation 

Tecnológico de Monterrey School of Medicine & Health Sciences

Cochrane Mexican Branch · Iberoamerican Cochrane Centre

Editorial Board, The Journal of Pediatrics

CITES piso 3. Morones Prieto 3000 pte. Col. Doctores 64710 

Monterrey, NL. Mexico. 

☎ +52.81.8888.2223 & 2154. Skype: dr.carlos.cuello

Facebook · Twitter · Linkedin 

The content of this data transmission must not be considered an offer, proposal, understanding or agreement unless it is confirmed in a document signed by a legal representative of ITESM. The content of this data transmission is confidential and is intended to be delivered only to the addressees. Therefore, it shall not be distributed and/or disclosed through any means without the authorization of the original sender. If you are not the addressee, you are forbidden from using it, either totally or partially, for any purpose